Cited by 374Cutaneous Melanoma Detection and ManagementAI in cancer detectionArtificial Intelligence in Healthcare and Education

What is AI? Applications of artificial intelligence to dermatology

Open access
Du‐Harpur, X., Watt, F.M., Luscombe, N.M., Lynch, M.D.·2020·British Journal of Dermatology

Abstract

In the past, the skills required to make an accurate dermatological diagnosis have required exposure to thousands of patients over many years. However, in recent years, artificial intelligence (AI) has made enormous advances, particularly in the area of image classification. This has led computer scientists to apply these techniques to develop algorithms that are able to recognize skin lesions, particularly melanoma. Since 2017, there have been numerous studies assessing the accuracy of algorithms, with some reporting that the accuracy matches or surpasses that of a dermatologist. While the principles underlying these methods are relatively straightforward, it can be challenging for the practising dermatologist to make sense of a plethora of unfamiliar terms in this domain. Here we explain the concepts of AI, machine learning, neural networks and deep learning, and explore the principles of how these tasks are accomplished. We critically evaluate the studies that have assessed the efficacy of these methods and discuss limitations and potential ethical issues. The burden of skin cancer is growing within the Western world, with major implications for both population skin health and the provision of dermatology services. AI has the potential to assist in the diagnosis of skin lesions and may have particular value at the interface between primary and secondary care. The emerging technology represents an exciting opportunity for dermatologists, who are the individuals best informed to explore the utility of this powerful novel diagnostic tool, and facilitate its safe and ethical implementation within healthcare systems.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bjd.18880

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 31 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Du‐Harpur, X., Watt, F. M., Luscombe, N. M., & Lynch, M. D.
Affiliations
  • Centre for Stem Cells and Regenerative Medicine Faculty of Life Sciences and Medicine King's College London 28th Floor, Tower Wing, Guy's Hospital London SE1 9RT UK
  • Guy's Hospital (GB)
  • Okinawa Institute of Science and Technology Graduate University (JP)
Venue
British Journal of Dermatology
Published
2020-03-29
Volume
183
Issue
3
Pages
423-430
ISSN
  • 0007-0963 (ISSN-L)
  • 1365-2133
OpenAlex
W3001446745
Cited by
355
References
31
Citations by year
2026: 50 · 2025: 94 · 2024: 93 · 2023: 45 · 2022: 30 · 2021: 28 · 2020: 15
FWCI
10.66
Type
journal article
Language
en
Open access
Locations
  • British Journal of Dermatology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
  • UCL Discovery (University College London) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Research Portal (King's College London) (submittedVersion, cc-by)
  • Okinawa Institute of Science and Technology Graduate University (Okinawa Institute of Science and Technology Graduate University) (submittedVersion, cc-by-nc-nd)
Funders
  • Biotechnology and Biological Sciences Research Council (BB/M007219/1)
  • Wellcome Trust (103760/Z/14/Z, 206439/Z/17/Z, 211276/E/18/Z, FC010110)
  • Cancer Research UK (FC010110)
  • Medical Research Council (FC010110, MR/L016311/1, MR/PO18823/1)
Topics
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Keywords
artificial intelligence, dermatology, skin lesion classification, melanoma diagnosis, machine learning, artificial neural networks, deep learning, image classification, diagnostic accuracy, ethical considerations, primary-secondary care interface
MeSH terms
Machine Learning, Algorithms, Artificial Intelligence, Dermatology, Humans, Neural Networks, Computer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review